Aisling Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,123,630	Closed	-$148M	–	17
2020 Q4	$148M	Hold	1,123,630	–	–	25.39%	2
2020 Q3	$56.8M	Hold	1,123,630	–	–	18.14%	2
2020 Q2	$53.6M	Hold	1,123,630	–	–	20.44%	2
2020 Q1	$55M	Hold	1,123,630	–	–	23.98%	2
2019 Q4	$64.5M	Hold	1,123,630	–	–	24.71%	2
2019 Q3	$40.4M	Hold	1,123,630	–	–	21.07%	2
2019 Q2	$34.9M	Hold	1,123,630	–	–	14.92%	2
2019 Q1	$26.3M	Hold	1,123,630	–	–	20.07%	1
2018 Q4	$15.5M	Buy	+1,123,630	New	+$15.5M	16.29%	2